Produktresuméet for andre proteasehæmmere eller andre officielle opdateringer bør konsulteres med hensyn til konkrete oplysninger vedrørende proteasemutationer associeret med nedsat respons på disse stoffer.
The Summary of Product Characteristics of other protease inhibitors or official continuous updates should be consulted for specific information regarding protease mutations associated with reduced response to these agents.